Holen Sie sich die Stockscreener-App
64.97
0.39%
-0.2143
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Assessing Disc Medicine (IRON) Valuation After FDA Complete Response Letter And Shareholder Investigation - Sahm
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Shareholders to Connect | NDAQ:IRON | Press Release - Stockhouse
Retail Trends: Should I invest in Disc Medicine Inc before earnings2026 Key Lessons & Risk Controlled Swing Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Disc Medicine, Inc. (IRON) And Encourages Shareholders to Reach Out - ACCESS Newswire
ROSEN Law Firm Encourages Disc Medicine Investors - National Today
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, - GlobeNewswire
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Disc Medicine, Inc. (IRON) And Encourages Shareholders to Reach Out | NDAQ:IRON | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Disc Medicine, Inc. (IRON) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Disc Medicine, Inc. (IRON) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Disc Medicine, Inc. (IRON) and Encourages Shareholders to Learn More About the Investigation | NDAQ:IRON | Press Release - Stockhouse
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.IRON - PR Newswire
Insider Buy: Will Disc Medicine Inc outperform during market rallies2026 Earnings & Low Volatility Stock Recommendations - baoquankhu1.vn
IRON Investors Lose Up to $22/Share -- LEVI & KORSINSKY, LLP Investigates Disc Medicine - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Disc Medicine, Inc. (IRON) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, ... - Bluefield Daily Telegraph
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are ... - Bluefield Daily Telegraph
IRON Investor News: If You Have Suffered Losses in Disc - GlobeNewswire
2026-03-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Disc Medicine, Inc. (IRON) and Encourages Investors to Learn More About the Investigation | NDAQ:IRON | Press Release - Stockhouse
Disc Medicine, Inc. (IRON) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
(IRON) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Stifel reiterates Disc Medicine stock rating after rival drug data By Investing.com - au.investing.com
Stifel reiterates Disc Medicine stock rating after rival drug data - Investing.com
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Investigation Alert: Levi & Korsinsky Investigates Securities Fraud Claims Against Disc Medicine, Inc. (IRON) - TMX Newsfile
Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Investors to Connect - ACCESS Newswire
Expanded Phase 3 APOLLO Enrollment for Bitopertin in EPP/XLP Might Change The Case For Investing In Disc Medicine (IRON) - Sahm
Bronstein, Gewirtz & Grossman, LLC Encourages Disc Medicine, Inc. (IRON) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
2026-03-27 | Bronstein, Gewirtz & Grossman, LLC Encourages Disc Medicine, Inc. (IRON) Stockholders to Inquire about Securities Investigation | NDAQ:IRON | Press Release - Stockhouse
Disc Medicine, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Disc Medicine completes enrollment in bitopertin EPP trial By Investing.com - Investing.com Australia
A Look At Disc Medicine (IRON) Valuation As APOLLO Phase 3 Trial Reaches Full Enrollment Milestone - Sahm
Published on: 2026-03-27 10:30:49 - baoquankhu1.vn
Disc Medicine completes enrollment in bitopertin EPP trial - Investing.com
Disc Medicine announces completion of enrollment of phase 3 Apollo trial of bitopertin in erythropoietic protoporphyria - marketscreener.com
Disc Medicine Announces Completion Of Enrollment Of Phase 3 Apollo Trial Of Bitopertin In Erythropoietic Protoporphyria - TradingView
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria - The Manila Times
Disc Medicine expands rare disease trial to 183 patients; data due in Q4 - Stock Titan
Assenagon Asset Management S.A. Grows Position in Disc Medicine, Inc. $IRON - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Stockholders to Connect - ACCESS Newswire
Disc Medicine, Inc. (IRON) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON - ChartMill
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON - FinancialContent
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Disc Medicine, Inc. (IRON) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Growth Review: Will Disc Medicine Inc outperform during market rallies2026 Technical Overview & Fast Gain Stock Trading Tips - baoquankhu1.vn
JPMorgan Chase & Co. Sells 90,737 Shares of Disc Medicine, Inc. $IRON - marketbeat.com
Hudson Bay Capital Management LP Acquires Shares of 102,185 Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine targets dermatology growth with new bitopertin update at AAD conference - Traders Union
Disc Medicine announces public offering of common stock and pre-funded warrants - MSN
Trade Recap: Is Disc Medicine Inc stock trending bullishDip Buying & Weekly Top Performers Watchlists - baoquankhu1.vn
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON - The Joplin Globe
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):